Artes Medical, a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, set the terms for its IPO on Monday. The San Diego-based company plans to offer 4.6 million shares at a range of $12-$14, giving it a proposed market cap of $221 million. Cowen & Company and Lazard are set to manage the deal. Timing has yet to be announced.
